La prescripción enfermera

Objetivos: Describir la situación de la prescripción enfermera. Revisar su desarrollo en otros países de nuestro entorno. Material y método: Revisión bibliográfica de libros, artículos y estudios realizados sobre la prescripción enfermera y las prácticas diarias que realizan los profesionales sanitarios de enfermería. Resultado: Una de las competencias de la profesión enfermera, es la toma de decisiones en relación con la administración de medicamentos, y de ella se deriva responsabilidad legal en cuanto que tiene una repercusión directa en la salud del paciente/usuario. Cuando la decisión a tomar implica la elección de fármaco o producto sanitario a administra, el profesional de enfermería se encuentra en situación de desamparo legal. Tras la modificación de ley en el año 2009 de las garantías y uso racional de los medicamentos y productos sanitarios se plantea la posibilidad de la prescripción enfermera, estableciendo que el Gobierno regulará la indicación, uso y autorización de dispensación de determinados medicamentos. La prescripción enfermera está implantada en otros países, adoptando diferentes modelos de desarrollo. Se presentan algunos ejemplos de cómo en España los enfermeros, en la práctica diaria realizan la prescripción de algunos medicamentos, por lo que entendemos que el desarrollo de la Ley 28/2009, conducirá a amparar dentro de la ley la labor diaria, en sentido, de los profesionales de enfermería, a la vez que supondrá un aumento de la responsabilidad en el ejercicio de la profesión. Conclusiones: Es necesario desarrollar la prescripción enfermera

Systems genomics study reveals expression quantitative trait loci, regulator genes and pathways associated with boar taint in pigs

<div><p>Boar taint is an offensive odour and/or taste from a proportion of non-castrated male pigs caused by skatole and androstenone accumulation during sexual maturity. Castration is widely used to avoid boar taint but is currently under debate because of animal welfare concerns. This study aimed to identify expression quantitative trait loci (eQTLs) with potential effects on boar taint compounds to improve breeding possibilities for reduced boar taint. Danish Landrace male boars with low, medium and high genetic merit for skatole and human nose score (HNS) were slaughtered at ~100 kg. Gene expression profiles were obtained by RNA-Seq, and genotype data were obtained by an Illumina 60K Porcine SNP chip. Following quality control and filtering, 10,545 and 12,731 genes from liver and testis were included in the eQTL analysis, together with 20,827 SNP variants. A total of 205 and 109 single-tissue eQTLs associated with 102 and 58 unique genes were identified in liver and testis, respectively. By employing a multivariate Bayesian hierarchical model, 26 eQTLs were identified as significant multi-tissue eQTLs. The highest densities of eQTLs were found on pig chromosomes SSC12, SSC1, SSC13, SSC9 and SSC14. Functional characterisation of eQTLs revealed functions within regulation of androgen and the intracellular steroid hormone receptor signalling pathway and of xenobiotic metabolism by cytochrome P450 system and cellular response to oestradiol. A QTL enrichment test revealed 89 QTL traits curated by the Animal Genome PigQTL database to be significantly overlapped by the genomic coordinates of <i>cis</i>-acting eQTLs. Finally, a subset of 35 <i>cis</i>-acting eQTLs overlapped with known boar taint QTL traits. These eQTLs could be useful in the development of a DNA test for boar taint but careful monitoring of other overlapping QTL traits should be performed to avoid any negative consequences of selection.</p></div

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

[Objective] To identify factors related to a poor health-related and global quality of life (QoL) in a cohort of non-demented Parkinson's disease (PD) patients and compare to a control group.[Methods] The data correspond to the baseline evaluation of the COPPADIS-2015 Study, an observational, 5-year follow-up, multicenter, evaluation study. Three instruments were used to assess QoL: (1) the 39-item Parkinson's disease Questionnaire (PDQ-39), (2) a subjective rating of global QoL (PQ-10), and (3) the EUROHIS-QOL 8-item index (EUROHIS-QOL8). Multiple linear regression methods were used to evaluate the direct impact of different variables on these QoL measures.[Results] QoL was worse in PD patients (n = 692; 62.6 ± 8.9 years old, 60.3% males) than controls (n = 206; 61 ± 8.3 years old, 49.5% males): PDQ-39, 17.1 ± 13.5 vs 4.4 ± 6.3 (p < 0.0001); PQ-10, 7.3 ± 1.6 vs 8.1 ± 1.2 (p < 0.0001); EUROHIS-QOL8, 3.8 ± 0.6 vs 4.2 ± 0.5 (p < 0.0001). A high correlation was observed between PDQ-39 and Non-Motor Symptoms Scale (NMSS) (r = 0.72; p < 0.0001), and PDQ-39 and Beck Depression Inventory-II (BDI-II) (r = 0.65; p < 0.0001). For health-related QoL (PDQ-39), non-motor symptoms burden (NMSS), mood (BDI-II), and gait problems (Freezing Of Gait Questionnaire [FOGQ]) provided the highest contribution to the model (β = 0.32, 0.28, and 0.27, respectively; p < 0.0001); whereas mood and gait problems contributed the most to global QoL (PQ-10, β = -0.46 and −0.21, respectively; EUROHIS-QOL8, β = -0.44 and −0.23, respectively).[Conclusions] QoL is worse in PD patients than in controls. Mood, non-motor symptoms burden, and gait problems seem to be the most relevant factors affecting health-related and global perceived QoL in non-demented PD patients.Peer reviewe